{
    "title": "Pharmaceuticals company AstraZeneca battles to beef up its drugs pipeline",
    "url": "https://www.dailymail.co.uk/money/markets/article-2223161/AstraZeneca-battles-beef-drugs-pipeline.html",
    "date": "2012-10-25",
    "keywords": [
        "company",
        "pipeline",
        "executive",
        "group",
        "russell",
        "acquisition",
        "research",
        "development",
        "patent",
        "protection",
        "treatment",
        "market",
        "cent",
        "period",
        "soriot",
        "shire",
        "mail",
        "october",
        "email",
        "view",
        "scale",
        "challenge",
        "bare",
        "yesterday",
        "half",
        "fall",
        "loss",
        "exclusivity",
        "impact",
        "seroquel",
        "pill",
        "nexium",
        "cholesterol",
        "crestor",
        "respectivelygroup",
        "end",
        "september",
        "boss",
        "share",
        "programme",
        "day",
        "job",
        "month",
        "battle",
        "city",
        "sign",
        "astra",
        "trail",
        "series",
        "setbacksfrenchman",
        "strategy",
        "quarter",
        "year",
        "time",
        "austerity",
        "departmentsoriot",
        "roche",
        "brennan",
        "shareholder",
        "pressure",
        "profit",
        "performance",
        "intention",
        "angus",
        "firmflemming",
        "ornskov",
        "bayer",
        "designate",
        "firm",
        "stock",
        "value"
    ],
    "category": [
        "money",
        "markets"
    ]
}